Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 6 recruiting now full pipeline

Sexually Transmitted Diseases: full-pipeline trial registry

6 of 36 indexed Sexually Transmitted Diseases trials are currently recruiting.

Corpus placement: #419 of 28,707 conditions by registered trial count.

36 US clinical trials · 6 currently recruiting · #419 of 28,707 conditions by registered trial count

Sexually Transmitted Diseases: 36 US clinical trials tracked, 6 recruiting.

Sexually Transmitted Diseases is the subject of 36 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 5 are in Phase 3-4 (later-stage) and 6 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, San Francisco, running 4 of these trials.

Enrollment posture brief

Registry condition sexually-transmitted-diseases

OPEN 6 | RECR 17% | LATE 5 | EARLY 6 | RANK #419 | SPON 4

Nearest open-share peer: Acute Renal Failure (17% recruiting · 6 trials)

Dysphagia63.9%Cognition50%Chronic Myeloid Leukemia38.9%Sexually Transmitted Dis (th…17%Coronary Disease2.8%
Open-enrollment share among volume-matched conditions near Sexually Transmitted Diseases

Sexually Transmitted Diseases lists 6 open slots (17% of 36 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Sexually Transmitted Diseases on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Sexually Transmitted Diseases is recruiting below its size-band peers.

    6 of 36 indexed trials (16.7%) are open to enrollment, against a 39.7% average across 762 conditions with 20-99 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. Sponsorship of Sexually Transmitted Diseases trials is spread across many organizations.

    University of California, San Francisco accounts for 4 of 36 trials (11.1%). 28 distinct sponsors appear on at least one study for this condition label.

  3. Typical Sexually Transmitted Diseases enrolment sits around 400 participants.

    Median target enrolment is 400 among the 36 trials that report a genuine target (sentinel values excluded). 7 of those (19.4%) plan for fewer than 100 participants.

  4. Sexually Transmitted Diseases research is mostly interventional.

    34 interventional and 2 observational studies make up this index (94.4% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 12Phase 24Phase 32Phase 43

Open and recent trials

36 total, page 1 of 1

RECRUITING NA 18,500 participants

Health Information Technology to Reduce Disparities in Adolescent Health Outcomes: A Pragmatic Trial

Children's National Research Institute

NCT04372875

RECRUITING NA 2,000 participants

Evaluation of Parent Toolkit 2.0 (Morehouse Family Health Study)

Child Trends

NCT06579781

RECRUITING NA 1,200 participants

Rigorous Evaluation of Yes and Know, a Fully Virtual Sexual Health and Well-Being Intervention for Youth

ETR Associates

NCT06581536

RECRUITING NA 400 participants

Improving Alcohol and Substance Use Care Access, Outcome, Equity During the Reproductive Years

Emory University

NCT05910580

RECRUITING NA 300 participants

Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention

Public Health Foundation Enterprises

NCT04855773

RECRUITING NA 270 participants

Using Mobile Health (mHealth) to Improve STI Treatment Adherence Among Adolescents

Children's National Research Institute

NCT04372485

ACTIVE NOT RECRUITING NA 2,250 participants

Evaluation of an Adolescent Pregnancy Prevention Program; Relationship Smarts+ With Lessons From Mind Matters

Trinity Church

NCT05889689

ACTIVE NOT RECRUITING NA 752 participants

Kentucky Outreach Service Kiosk (KyOSK): Reducing HIV, HCV, and Overdose Risk

April M Young

NCT05657106

ACTIVE NOT RECRUITING NA 279 participants

Sexual Health Empowerment for Women's Health

University of Kansas Medical Center

NCT03984695

COMPLETED NA 3,098 participants

Engineering an Online STI Prevention Program: RCT

Penn State University

NCT04095065

COMPLETED 2,831 participants

Improving Adolescent Health Outcomes Through Preventive Care Transformation

Indiana University

NCT02244138

COMPLETED Phase 1 2,210 participants

Parents Matter!: Interventions to Promote Effective Parent-Child Communication

Centers for Disease Control and Prevention

NCT00137943

COMPLETED NA 1,450 participants

Louisville Teen Pregnancy Prevention Project

University of Louisville

NCT01411878

COMPLETED NA 1,260 participants

Personal Responsibility Education Program Innovative Strategies: Digital Initiative for Youth

University of California, San Francisco

NCT03765255

COMPLETED Phase 4 1,233 participants

Effectiveness of Integrating Prenatal Care in Reducing HIV/STDs Among Young Pregnant Women

Yale University

NCT00628771

COMPLETED Phase 3 1,010 participants

Reducing Sexual Risk Behaviors and Improving Health for People at a Sexually Transmitted Infection Clinic

The Miriam Hospital

NCT00947271

COMPLETED Phase 2 746 participants

A Peer-Oriented HIV Prevention Outreach Program for Individuals at High Risk for HIV and Other STIs

Johns Hopkins Bloomberg School of Public Health

NCT00183456

COMPLETED NA 600 participants

Synthetic Male Condom Slippage-Breakage Study

Church & Dwight Company

NCT05370196

COMPLETED NA 574 participants

Internet-Based Sexual Health Education for Middle School Native American Youth

The University of Texas Health Science Center, Houston

NCT01303575

COMPLETED Phase 3 530 participants

Reducing HIV & Domestic Violence Risk in Women Offenders

Multnomah County Health Department

NCT00289939

COMPLETED NA 480 participants

Protect and Connect: Couple HIV Prevention for Drug Involved Male Offenders

Columbia University

NCT01690494

COMPLETED Phase 1 341 participants

Evaluation of Many Men, Many Voices, An STD/HIV Prevention Intervention for Black MSM

Centers for Disease Control and Prevention

NCT00137631

COMPLETED Phase 2 319 participants

Safety of and Immune Response to the Human Papillomavirus (HPV) Vaccine in HIV-Infected Women

National Institute of Allergy and Infectious Diseases (NIAID)

NCT00604175

COMPLETED NA 166 participants

Advancing HIV Prevention and Linkage to Care Among MSM With Gamification

University of California, Berkeley

NCT02946164

COMPLETED 150 participants

Preventive Sexual Health Screening Among Female-to-Male (FTM) Transgender Adult Patients

Fenway Community Health

NCT02401867

COMPLETED NA 148 participants

Acceptability, Feasibility, and Preliminary Impact of a Web-based, HIV Prevention Toolkit With Cisgender Male Couples in Lima, Peru

Florida International University

NCT05873855

COMPLETED NA 141 participants

The OPENS Trial: Offering Women PrEP (Aim 2)

University of California, San Francisco

NCT05619497

COMPLETED Phase 2 130 participants

Safety of and Immune Response to a Novel Human Papillomavirus Vaccine in HIV Infected Children

National Institute of Allergy and Infectious Diseases (NIAID)

NCT00339040

COMPLETED Phase 2 120 participants

Addressing Heavy Alcohol Use Consumption With Kudzu

Glenn-Milo Santos

NCT03709043

COMPLETED NA 91 participants

Enhanced SexHealth Intervention to Improve Adolescent Outcomes

Children's Mercy Hospital Kansas City

NCT03341975

COMPLETED NA 75 participants

Zenyth: Motivational Interviewing-based Telehealth Intervention for Bacterial Sexually Transmitted Infection Screening

University of Michigan

NCT06100250

COMPLETED Phase 4 33 participants

Mesalamine to Reduce T Cell Activation in HIV Infection

University of California, San Francisco

NCT01090102

COMPLETED NA 33 participants

Adopting and Demonstrating the Adaptation of Prevention Techniques (ADAPT), Harlem United Community AIDS Center

Centers for Disease Control and Prevention

NCT00267410

COMPLETED NA 30 participants

CRUSH-PrEP for Women Project

University of California, San Francisco

NCT02852226

COMPLETED Phase 4 20 participants

Combo-PEP: Multipurpose Prevention of Post-Exposure Prophylaxis Regimens

Emory University

NCT04860505

COMPLETED NA 14 participants

Distress Tolerance and HIV Prevention With XR-NTX Initiation in Opioid Dependence

Rhode Island Hospital

NCT02602795

Phase Distribution

PhaseTrial count
Phase 1 2
Phase 2 4
Phase 3 2
Phase 4 3

Named interventions

Most-linked intervention names on Sexually Transmitted Diseases records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Control Curricula Behavioral
1 trials
HIV, STI and Pregnancy Prevention Curriculum Behavioral
1 trials
Quadrivalent HPV vaccine Biological
1 trials
Control Product Device
1 trials
Test Product Device
1 trials
Many Men, Many Voices (3MV) Behavioral
1 trials
Stick To It Behavioral
1 trials
Adolescent CDSS Behavioral
1 trials

US sites by state

Facility locations filed on Sexually Transmitted Diseases trials. A trial with sites in several states counts in each.

California 11 trials
Florida 6 trials
New York 5 trials
Massachusetts 4 trials
Georgia 4 trials
Oregon 2 trials
Missouri 2 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Sexually Transmitted Diseases page

36 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Sexually Transmitted Diseases condition card totals 36 registered trials; most-linked intervention Control Curricula; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.